Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-1993 | 01-1993 | 10-1992 | 07-1992 | 04-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30 | 1,056 | N/A | N/A | 136 |
| Marketable Securities | 700 | 30 | N/A | N/A | 750 |
| Receivables | 50 | 73 | N/A | N/A | 91 |
| Inventories | 140 | 94 | N/A | N/A | 60 |
| Other current assets | 90 | 289 | 0 | 0 | 93 |
| TOTAL | $1,010 | $1,541 | $N/A | $N/A | $1,130 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,539 | N/A | N/A | 1,127 |
| Investments And Advances | 0 | 38 | 0 | 0 | 0 |
| Other Non-Current Assets | 170 | 189 | 0 | 0 | 50 |
| TOTAL | $170 | $1,766 | $N/A | $N/A | $1,177 |
| Total Assets | $2,320 | $2,894 | $N/A | $N/A | $1,998 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 120 | 204 | 0 | 0 | 270 |
| Accrued Expenses | 70 | 126 | N/A | N/A | 270 |
| Other current liabilities | 70 | 149 | N/A | N/A | 160 |
| TOTAL | $360 | $491 | $N/A | $N/A | $1,567 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 121 | N/A | N/A | N/A |
| TOTAL | $130 | $140 | $N/A | $N/A | $110 |
| Total Liabilities | $490 | $631 | $N/A | $N/A | $1,679 |
| Shareholders' Equity | |||||
| Common Shares | 7 | 5 | N/A | N/A | 5 |
| Retained earnings | -3,910 | -3,526 | N/A | N/A | -2,761 |
| Other shareholders' equity | 643 | 4,460 | 0 | 0 | 236 |
| TOTAL | $1,830 | $2,263 | $N/A | $N/A | $319 |
| Total Liabilities And Equity | $2,320 | $2,894 | $0 | $0 | $1,998 |